Asmodee Group AB, B shares (ASMDEE-B)
Stockholm Exchange · Sweden · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 171.90 |
|---|---|
| 52-week range | 91.28 – 174.70 |
| Return, 1 month / 3 months | +2.0% / +15.7% |
| Return, 1 year / 3 years | +43.3% / – |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 29.3% |
| Worst drawdown (1 year) | -22.6% |
| Average daily value traded | 39.80M SEK |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Asmodee Group is a publisher and distributor of board games, card games and tabletop games, based in France. Its catalogue includes family and hobby games such as Catan, Ticket to Ride and Dobble, along with role-playing and collectible card games. The company sells through hobby shops, bookstores and general retailers, and it also runs game studios and distribution businesses in several countries across Europe, North America and Asia.
The shares are listed on the Stockholm Exchange in Sweden under the code ASMDEE-B, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Asmodee Group AB, B shares (ASMDEE-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 171.90 on 22 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 53 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 43.3% and over the last three months it rose 15.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 28.9% | ||
| From 52-week high | -1.2% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.7% | ||
| 6-month return | 40.1% | ||
| 12-month return, skipping the last month | 40.5% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.6% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 39.80M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 2 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.5% |
|---|---|
| 1 month | +2.0% |
| 3 months | +15.7% |
| 6 months | +40.1% |
| 1 year | +43.3% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 162.24 / 133.33 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Sep 2026 | SEK 0.5570 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.